Panacea Biotec
Panacea Biotec Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Panacea Biotec
Start SIPPanacea Biotec Investment Rating
-
Master Rating:
-
Panacea Biotec (Nse) has an operating revenue of Rs. 471.75 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 219% is great, ROE of 126% is exceptional. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 70 which is a FAIR score but needs to improve its earnings, a RS Rating of 18 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 81 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 72 | 49 | 61 | 42 |
| Operating Expenses Qtr Cr | 60 | 55 | 133 | 61 |
| Operating Profit Qtr Cr | 12 | -6 | -72 | -19 |
| Depreciation Qtr Cr | 6 | 6 | 6 | 7 |
| Interest Qtr Cr | 3 | 2 | 2 | 1 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 13 | -7 | -74 | -25 |
Panacea Biotec Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 14
- 20 Day
- 117.97
- 50 Day
- 123.86
- 100 Day
- 129.72
- 200 Day
- 141.52
- 20 Day
- 118.55
- 50 Day
- 124.65
- 100 Day
- 132.69
- 200 Day
- 134.26
Panacea Biotec Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 113.54 |
| Second Resistance | 115.32 |
| Third Resistance | 117.14 |
| RSI | 34.39 |
| MFI | 40.61 |
| MACD Single Line | -3.01 |
| MACD | -3.55 |
| Support | |
|---|---|
| First Resistance | 109.94 |
| Second Resistance | 108.12 |
| Third Resistance | 106.34 |
Panacea Biotec Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 40,646 | 2,478,187 | 60.97 |
| Week | 51,425 | 3,170,878 | 61.66 |
| 1 Month | 59,258 | 3,864,835 | 65.22 |
| 6 Month | 125,072 | 5,454,377 | 43.61 |
Panacea Biotec Result Highlights
Panacea Biotec Synopsis
NSE-Medical-Generic Drugs
Panacea Biotec L is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 235.50 Cr. and Equity Capital is Rs. 6.13 Cr. for the Year ended 31/03/2022. Panacea Biotec Ltd. is a Public Limited Listed company incorporated on 02/02/1984 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L33117PB1984PLC022350 and registration number is 022350.| Market Cap | 695 |
| Sales | 224 |
| Shares in Float | 1.59 |
| No of funds | 7 |
| Yield |
| Book Value | 1.77 |
| U/D Vol ratio | 0.8 |
| LTDebt / Equity | 20 |
| Alpha | -0.15 |
| Beta | 0.53 |
Panacea Biotec
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 73.59% | 73.59% | 73.59% | |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 0.18% | 0.14% | ||
| Individual Investors | 15.97% | 15.79% | 15.6% | |
| Others | 10.26% | 10.48% | 10.81% |
Panacea Biotec Management
| Name | Designation |
|---|---|
| Mr. Soshil Kumar Jain | Chairman |
| Dr. Rajesh Jain | Managing Director |
| Mr. Sandeep Jain | Joint Managing Director |
| Mr. Ankesh Jain | Whole Time Director |
| Mr. R L Narasimhan | Non Executive Director |
| Mr. N N Khamitkar | Non Executive Director |
| Mr. K M Lal | Non Executive Director |
| Mrs. Manjula Upadhyay | Non Executive Director |
| Mr. Bhupinder Singh | Non Executive Director |
| Mr. Mukul Gupta | Non Executive Director |
| Mr. Narotam Kumar Juneja | Non Executive Director |
Panacea Biotec Forecast
Price Estimates
Panacea Biotec FAQs
What is Share Price of Panacea Biotec ?
Panacea Biotec share price is ₹113 As on 23 March, 2023 | 01:00
What is the Market Cap of Panacea Biotec ?
The Market Cap of Panacea Biotec is ₹695.2 Cr As on 23 March, 2023 | 01:00
What is the P/E ratio of Panacea Biotec ?
The P/E ratio of Panacea Biotec is 0.6 As on 23 March, 2023 | 01:00
What is the PB ratio of Panacea Biotec ?
The PB ratio of Panacea Biotec is 0.8 As on 23 March, 2023 | 01:00